Table 1.
Age in months (Age) and number (N) of the mice with successful TSPO-PET for each group (P301S mice with pioglitazone treatment (P301S + Pio), P301S mice with placebo treatment (P301S + Placebo), wild-type mice with pioglitazone treatment (WT + Pio), and wild-type mice with placebo treatment (WT + Placebo), as well as number of mice available for immunohistochemistry (IHC)). f = female.
| BL Age |
FU1 Age |
FU2 Age |
FU3 Age |
IHC N |
|||||
|---|---|---|---|---|---|---|---|---|---|
| N | N | N | N | ||||||
| P301S + Pio | 2.6 | 8 (f) | 5.9 | 7 (f) | 7.3 | 8 (f) | 8.2 | 8 (f) | 6 (f) |
| P301S + Placebo | 2.6 | 6 (f) | 6.0 | 6 (f) | 7.3 | 7 (f) | 8.2 | 7 (f) | 7 (f) |
| WT + Pio | 2.8 | 4 (f) | 5.9 | 2 (f) | 7.7 | 6 (f) | 8.2 | 4 (f) | 0 |
| WT + Placebo | 2.9 | 6 (f) | 5.0 | 10 (f) | 7.4 | 6 (f) | 8.4 | 4 (f) | 0 |